About Robert Bogden
Robert Bogden is a chief executive officer (ceo) and director at Hexamer Therapeutics.
Robert Bogden first appears on SEC filings in 2019.
Experience
This experience comes from Robert Bogden's profile and from SEC filings. For roles taken from filings, the years are when the filings name Robert Bogden in the role, so the role may have started earlier or lasted longer.
Hexamer Therapeutics, Inc Current
Chief Executive Officer (CEO) and director
CEO & Co-Founder (2019 – Present)
2019 – Present · Pullman, WA
Develops vaccine technologies for human cancer and infectious diseases and for animal health companies.
WU
Washington State University Current
Associate Professor
2007 – Present
AL
Amplicon Vaccine LLC Current
President & Founder
2004 – Present
AI
Amplicon Express Inc Current
President & CEO
1996 – Present
MG
Myriad Genetics
Molecular Biologist
1993 – 1996
HI
Howard Hughes Medical Institute
Molecular Biologist
1990 – 1993
Key Colleagues at Startups
The people Robert Bogden works with at each company, as listed on that company's latest Form D.
Hexamer Therapeutics, Inc · Form D, Sep 15, 2026
BC
Brad Call
Director
RB
R. Scott Blackley
Director
Keith Miller
Chief Technology Officer (CTO) and director
CC
Colin Collins
Chief Scientific Officer and Co-Founder, director
SC
Stephen Crawford
Director